
| MICRON TECHNOLOGY, INC. | ||
| (Exact name of registrant as specified in its charter) | ||
| Delaware | 1-10658 | 75-1618004 | ||||||||||||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
| 8000 South Federal Way | ||
Boise, Idaho 83716-9632 | ||
| (Address of principal executive offices and Zip Code) | ||
(208) 368-4000 | ||
| (Registrant’s telephone number, including area code) | ||
| Title of each class | Trading symbol | Name of each exchange on which registered | ||||||||||||
| Common Stock, par value $0.10 per share | MU | Nasdaq Global Select Market | ||||||||||||
| Item 2.02. | Results of Operations and Financial Condition. | ||||
| Item 9.01. | Financial Statements and Exhibits. | ||||
| (d) Exhibits. | |||||
| Exhibit No. | Description | |||||||
| 99.1 | ||||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
| MICRON TECHNOLOGY, INC. | |||||||||||
| Date: | March 18, 2026 | By: | /s/ Mark Murphy | ||||||||
| Name: | Mark Murphy | ||||||||||
| Title: | Executive Vice President and Chief Financial Officer | ||||||||||
| Contacts: | Satya Kumar | Mark Plungy | ||||||
| Investor Relations | Media Relations | |||||||
satyakumar@micron.com | mplungy@micron.com | |||||||
(408) 450-6199 | (408) 203-2910 | |||||||
| Quarterly Financial Results | |||||||||||||||||||||||
| (in millions, except per share amounts) | GAAP(1) | Non-GAAP(2) | |||||||||||||||||||||
| FQ2-26 | FQ1-26 | FQ2-25 | FQ2-26 | FQ1-26 | FQ2-25 | ||||||||||||||||||
| Revenue | $ | 23,860 | $ | 13,643 | $ | 8,053 | $ | 23,860 | $ | 13,643 | $ | 8,053 | |||||||||||
| Gross margin | 17,755 | 7,646 | 2,963 | 17,876 | 7,753 | 3,053 | |||||||||||||||||
| Percent of revenue | 74.4 | % | 56.0 | % | 36.8 | % | 74.9 | % | 56.8 | % | 37.9 | % | |||||||||||
| Operating expenses | 1,620 | 1,510 | 1,190 | 1,421 | 1,334 | 1,046 | |||||||||||||||||
| Operating income | 16,135 | 6,136 | 1,773 | 16,455 | 6,419 | 2,007 | |||||||||||||||||
| Percent of revenue | 67.6 | % | 45.0 | % | 22.0 | % | 69.0 | % | 47.0 | % | 24.9 | % | |||||||||||
| Net income | 13,785 | 5,240 | 1,583 | 14,021 | 5,482 | 1,783 | |||||||||||||||||
| Diluted earnings per share (EPS) | 12.07 | 4.60 | 1.41 | 12.20 | 4.78 | 1.56 | |||||||||||||||||
FQ3-26 | GAAP(1) Outlook | Non-GAAP(2) Outlook | ||||||
Revenue | $33.5 billion ± $750 million | $33.5 billion ± $750 million | ||||||
Gross margin | Approximately 81% | Approximately 81% | ||||||
Operating expenses | Approximately $1.60 billion | Approximately $1.40 billion | ||||||
Diluted earnings per share | $18.90 ± $0.40 | $19.15 ± $0.40 | ||||||
2nd Qtr. | 1st Qtr. | 2nd Qtr. | Six Months Ended | ||||||||||||||
| February 26, 2026 | November 27, 2025 | February 27, 2025 | February 26, 2026 | February 27, 2025 | |||||||||||||
| Revenue | $ | 23,860 | $ | 13,643 | $ | 8,053 | $ | 37,503 | $ | 16,762 | |||||||
| Cost of goods sold | 6,105 | 5,997 | 5,090 | 12,102 | 10,451 | ||||||||||||
| Gross margin | 17,755 | 7,646 | 2,963 | 25,401 | 6,311 | ||||||||||||
| Research and development | 1,250 | 1,171 | 898 | 2,421 | 1,786 | ||||||||||||
| Selling, general, and administrative | 344 | 337 | 285 | 681 | 573 | ||||||||||||
| Other operating (income) expense, net | 26 | 2 | 7 | 28 | 5 | ||||||||||||
| Operating income | 16,135 | 6,136 | 1,773 | 22,271 | 3,947 | ||||||||||||
| Interest income | 155 | 139 | 108 | 294 | 215 | ||||||||||||
| Interest expense | (32) | (74) | (112) | (106) | (230) | ||||||||||||
| Other non-operating income (expense), net | (98) | (140) | (11) | (238) | (22) | ||||||||||||
| 16,160 | 6,061 | 1,758 | 22,221 | 3,910 | |||||||||||||
| Income tax (provision) benefit | (2,371) | (829) | (177) | (3,200) | (460) | ||||||||||||
| Equity in net income (loss) of equity method investees | (4) | 8 | 2 | 4 | 3 | ||||||||||||
| Net income | $ | 13,785 | $ | 5,240 | $ | 1,583 | $ | 19,025 | $ | 3,453 | |||||||
| Earnings per share | |||||||||||||||||
| Basic | $ | 12.25 | $ | 4.66 | $ | 1.42 | $ | 16.91 | $ | 3.10 | |||||||
| Diluted | 12.07 | 4.60 | 1.41 | 16.68 | 3.08 | ||||||||||||
| Number of shares used in per share calculations | |||||||||||||||||
| Basic | 1,126 | 1,125 | 1,115 | 1,125 | 1,113 | ||||||||||||
| Diluted | 1,142 | 1,138 | 1,123 | 1,140 | 1,123 | ||||||||||||
| As of | February 26, 2026 | November 27, 2025 | August 28, 2025 | ||||||||
| Assets | |||||||||||
| Cash and equivalents | $ | 13,908 | $ | 9,731 | $ | 9,642 | |||||
| Short-term investments | 681 | 587 | 665 | ||||||||
| Receivables | 17,314 | 10,184 | 9,265 | ||||||||
| Inventories | 8,267 | 8,205 | 8,355 | ||||||||
| Other current assets | 1,243 | 958 | 914 | ||||||||
| Total current assets | 41,413 | 29,665 | 28,841 | ||||||||
| Long-term marketable investments | 2,038 | 1,697 | 1,629 | ||||||||
| Property, plant, and equipment | 51,408 | 48,477 | 46,590 | ||||||||
| Operating lease right-of-use assets | 684 | 700 | 736 | ||||||||
| Intangible assets | 468 | 465 | 453 | ||||||||
| Deferred tax assets | 680 | 641 | 616 | ||||||||
| Goodwill | 1,150 | 1,150 | 1,150 | ||||||||
| Other noncurrent assets | 3,668 | 3,176 | 2,783 | ||||||||
| Total assets | $ | 101,509 | $ | 85,971 | $ | 82,798 | |||||
| Liabilities and equity | |||||||||||
| Accounts payable and accrued expenses | $ | 10,997 | $ | 9,796 | $ | 9,649 | |||||
| Current debt | 585 | 569 | 560 | ||||||||
| Other current liabilities | 2,714 | 1,695 | 1,245 | ||||||||
| Total current liabilities | 14,296 | 12,060 | 11,454 | ||||||||
| Long-term debt | 9,557 | 11,187 | 14,017 | ||||||||
| Noncurrent operating lease liabilities | 656 | 669 | 701 | ||||||||
| Noncurrent unearned government incentives | 1,002 | 1,148 | 1,018 | ||||||||
| Other noncurrent liabilities | 3,539 | 2,101 | 1,443 | ||||||||
| Total liabilities | 29,050 | 27,165 | 28,633 | ||||||||
| Commitments and contingencies | |||||||||||
| Shareholders’ equity | |||||||||||
| Common stock | 127 | 127 | 127 | ||||||||
| Additional capital | 14,092 | 13,610 | 13,339 | ||||||||
| Retained earnings | 66,824 | 53,344 | 48,583 | ||||||||
| Treasury stock | (8,502) | (8,152) | (7,852) | ||||||||
| Accumulated other comprehensive income (loss) | (82) | (123) | (32) | ||||||||
| Total equity | 72,459 | 58,806 | 54,165 | ||||||||
| Total liabilities and equity | $ | 101,509 | $ | 85,971 | $ | 82,798 | |||||
| Six Months Ended | February 26, 2026 | February 27, 2025 | ||||||
| Cash flows from operating activities | ||||||||
| Net income | $ | 19,025 | $ | 3,453 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Depreciation expense and amortization of intangible assets | 4,498 | 4,109 | ||||||
Stock-based compensation | 599 | 469 | ||||||
Change in operating assets and liabilities: | ||||||||
| Receivables | (8,298) | 338 | ||||||
| Inventories | 88 | (132) | ||||||
| Accounts payable and accrued expenses | 928 | (714) | ||||||
Other current liabilities | 1,469 | (321) | ||||||
| Other noncurrent liabilities | 2,106 | 195 | ||||||
| Other | (101) | (211) | ||||||
| Net cash provided by operating activities | 20,314 | 7,186 | ||||||
| Cash flows from investing activities | ||||||||
| Expenditures for property, plant, and equipment | (11,776) | (7,261) | ||||||
| Purchases of available-for-sale securities | (1,120) | (816) | ||||||
| Proceeds from government incentives | 2,256 | 1,028 | ||||||
Proceeds from maturities and sales of available-for-sale securities | 701 | 874 | ||||||
| Other | (180) | (125) | ||||||
| Net cash used for investing activities | (10,119) | (6,300) | ||||||
| Cash flows from financing activities | ||||||||
| Repayments of debt | (4,626) | (2,626) | ||||||
| Repurchases of common stock - repurchase program | (650) | — | ||||||
Repurchases of common stock - withholdings on employee equity awards | (545) | (252) | ||||||
| Payments of dividends to shareholders | (266) | (261) | ||||||
Proceeds from issuance of debt | — | 2,682 | ||||||
| Other | 175 | 131 | ||||||
Net cash used for financing activities | (5,912) | (326) | ||||||
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash | 5 | (49) | ||||||
Net increase in cash, cash equivalents, and restricted cash | 4,288 | 511 | ||||||
| Cash, cash equivalents, and restricted cash at beginning of period | 9,646 | 7,052 | ||||||
| Cash, cash equivalents, and restricted cash at end of period | $ | 13,934 | $ | 7,563 | ||||
| 2nd Qtr. | 1st Qtr. | 2nd Qtr. | |||||||||
| February 26, 2026 | November 27, 2025 | February 27, 2025 | |||||||||
| GAAP gross margin | $ | 17,755 | $ | 7,646 | $ | 2,963 | |||||
| Stock-based compensation | 121 | 107 | 89 | ||||||||
| Other | — | — | 1 | ||||||||
| Non-GAAP gross margin | $ | 17,876 | $ | 7,753 | $ | 3,053 | |||||
| GAAP operating expenses | $ | 1,620 | $ | 1,510 | $ | 1,190 | |||||
| Stock-based compensation | (176) | (173) | (144) | ||||||||
| Other | (23) | (3) | — | ||||||||
| Non-GAAP operating expenses | $ | 1,421 | $ | 1,334 | $ | 1,046 | |||||
| GAAP operating income | $ | 16,135 | $ | 6,136 | $ | 1,773 | |||||
| Stock-based compensation | 297 | 280 | 233 | ||||||||
| Other | 23 | 3 | 1 | ||||||||
| Non-GAAP operating income | $ | 16,455 | $ | 6,419 | $ | 2,007 | |||||
GAAP net income | $ | 13,785 | $ | 5,240 | $ | 1,583 | |||||
| Stock-based compensation | 297 | 280 | 233 | ||||||||
| Loss on debt prepayments | 47 | 130 | 4 | ||||||||
| Other | 25 | (20) | — | ||||||||
Estimated tax effects of above and other tax adjustments | (133) | (148) | (37) | ||||||||
| Non-GAAP net income | $ | 14,021 | $ | 5,482 | $ | 1,783 | |||||
GAAP weighted-average common shares outstanding - Diluted | 1,142 | 1,138 | 1,123 | ||||||||
Adjustment for stock-based compensation | 7 | 10 | 20 | ||||||||
Non-GAAP weighted-average common shares outstanding - Diluted | 1,149 | 1,148 | 1,143 | ||||||||
GAAP diluted earnings per share | $ | 12.07 | $ | 4.60 | $ | 1.41 | |||||
Effects of the above adjustments | 0.13 | 0.18 | 0.15 | ||||||||
Non-GAAP diluted earnings per share | $ | 12.20 | $ | 4.78 | $ | 1.56 | |||||
| 2nd Qtr. | 1st Qtr. | 2nd Qtr. | |||||||||
| February 26, 2026 | November 27, 2025 | February 27, 2025 | |||||||||
GAAP net cash provided by operating activities | $ | 11,903 | $ | 8,411 | $ | 3,942 | |||||
Expenditures for property, plant, and equipment | (6,387) | (5,389) | (4,055) | ||||||||
| Proceeds from sales of property, plant, and equipment | 5 | 6 | 7 | ||||||||
Proceeds from government incentives | 1,378 | 878 | 963 | ||||||||
| Investments in capital expenditures, net | (5,004) | (4,505) | (3,085) | ||||||||
Adjusted free cash flow | $ | 6,899 | $ | 3,906 | $ | 857 | |||||
FQ3-26 | GAAP Outlook | Adjustments | Non-GAAP Outlook | ||||||||||||||||||||
Revenue | $33.5 billion ± $750 million | — | $33.5 billion ± $750 million | ||||||||||||||||||||
Gross margin | Approximately 81% | — | A | Approximately 81% | |||||||||||||||||||
Operating expenses | Approximately $1.60 billion | $200 million | B | Approximately $1.40 billion | |||||||||||||||||||
Diluted earnings per share(1) | $18.90 ± $0.40 | $0.25 | A, B, C | $19.15 ± $0.40 | |||||||||||||||||||
Non-GAAP Adjustments (in millions) | |||||||||||||||||||||||
A | Stock-based compensation – cost of goods sold | $ | 141 | ||||||||||||||||||||
B | Stock-based compensation – research and development | 132 | |||||||||||||||||||||
B | Stock-based compensation – sales, general, and administrative | 68 | |||||||||||||||||||||
C | Tax effects of the above items and other tax adjustments | (52) | |||||||||||||||||||||
| $ | 289 | ||||||||||||||||||||||